Status:

RECRUITING

Intervention for Communication Quality of Life in Primary Progressive Aphasia

Lead Sponsor:

University of Texas at Austin

Collaborating Sponsors:

National Institutes of Health (NIH)

National Institute on Aging (NIA)

Conditions:

Primary Progressive Aphasia(PPA)

Semantic Dementia

Eligibility:

All Genders

40+ years

Phase:

NA

Brief Summary

The goal of this clinical trial is to determine whether individually tailored speech-language telerehabilitation helps improve communication in people with primary progressive aphasia (PPA), a form of...

Eligibility Criteria

Inclusion

  • Inclusion Criteria for Persons with PPA:
  • A PPA (Gorno-Tempini et al., 2011) or "PPA-plus" (Mesulam et al., 2001) diagnosis
  • MMSE score of \> 15 and must be able to produce single monosyllabic words intelligibly.
  • Must speak English, Spanish or both languages (i.e., bilingual speakers of English or Spanish)
  • Hearing and vision adequate for participation in teleconference meetings
  • Must have a care partner available (someone who will commit to attending teleconference sessions weekly during treatment phases)
  • Inclusion criteria for Care Partners:
  • Partners must express willingness to attend and participate in treatment sessions including those targeting dyadic communication goals
  • Partners must speak English, Spanish or both languages (i.e., bilingual speakers of English or Spanish)
  • Partner's hearing and vision should be adequate for participation in teleconference meetings
  • Exclusion criteria for persons with PPA:
  • Other central nervous system or medical diagnosis that can account for symptoms
  • Psychiatric diagnosis that can account for symptoms
  • The participant and/or study partner must have basic experience using a computer.

Exclusion

    Key Trial Info

    Start Date :

    January 3 2026

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    August 1 2027

    Estimated Enrollment :

    25 Patients enrolled

    Trial Details

    Trial ID

    NCT07219680

    Start Date

    January 3 2026

    End Date

    August 1 2027

    Last Update

    November 4 2025

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    University of Texas

    Austin, Texas, United States, 78712